TransMedics Net Invested Capital from 2010 to 2025

TMDX Stock  USD 70.44  0.12  0.17%   
TransMedics Net Invested Capital yearly trend continues to be fairly stable with very little volatility. Net Invested Capital is likely to outpace its year average in 2025. Net Invested Capital is the total amount of capital invested in a company, including both equity and debt, minus any cash or cash equivalents. View All Fundamentals
 
Net Invested Capital  
First Reported
2020-03-31
Previous Quarter
718.5 M
Current Value
737.9 M
Quarterly Volatility
260.6 M
 
Covid
Check TransMedics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among TransMedics' main balance sheet or income statement drivers, such as Interest Expense of 15.1 M, Selling General Administrative of 177 M or Operating Income of 39.4 M, as well as many indicators such as Price To Sales Ratio of 4.46, Dividend Yield of 0.0 or PTB Ratio of 9.52. TransMedics financial statements analysis is a perfect complement when working with TransMedics Valuation or Volatility modules.
  
Check out the analysis of TransMedics Correlation against competitors.

Latest TransMedics' Net Invested Capital Growth Pattern

Below is the plot of the Net Invested Capital of TransMedics Group over the last few years. It is the total amount of capital invested in a company, including both equity and debt, minus any cash or cash equivalents. TransMedics' Net Invested Capital historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in TransMedics' overall financial position and show how it may be relating to other accounts over time.
Net Invested Capital10 Years Trend
Slightly volatile
   Net Invested Capital   
       Timeline  

TransMedics Net Invested Capital Regression Statistics

Arithmetic Mean92,553,981
Geometric Mean181,822,993
Coefficient Of Variation366.49
Mean Deviation261,059,477
Median28,845,000
Standard Deviation339,197,635
Sample Variance115055T
Range934.9M
R-Value0.88
Mean Square Error28580.9T
R-Squared0.77
Slope62,442,746
Total Sum of Squares1725825.5T

TransMedics Net Invested Capital History

2025774.8 M
2024737.9 M
2023643.4 M
2022246.1 M
2021103.1 M
2020138.5 M
201988.8 M

About TransMedics Financial Statements

TransMedics investors use historical fundamental indicators, such as TransMedics' Net Invested Capital, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in TransMedics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Net Invested Capital737.9 M774.8 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for TransMedics Stock Analysis

When running TransMedics' price analysis, check to measure TransMedics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TransMedics is operating at the current time. Most of TransMedics' value examination focuses on studying past and present price action to predict the probability of TransMedics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TransMedics' price. Additionally, you may evaluate how the addition of TransMedics to your portfolios can decrease your overall portfolio volatility.